WKN: | A1C3EQ |
ISIN: | US69404D1081 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Pacific Biosciences of California-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 24. Juli 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2020 | 4,60 | 21,00 | 356,52% |
2 | 2013 | 1,24 | 3,71 | 199,19% |
3 | 2018 | 2,22 | 6,44 | 190,09% |
4 | 2015 | 6,32 | 12,11 | 91,61% |
5 | 2014 | 3,71 | 6,32 | 70,35% |
6 | 2023 | 7,63 | 9,20 | 20,58% |
7 | 2021 | 21,00 | 16,96 | -19,24% |
8 | 2025 | 1,77 | 1,27 | -28,25% |
9 | 2019 | 6,44 | 4,60 | -28,57% |
10 | 2012 | 2,01 | 1,24 | -38,31% |
11 | 2017 | 3,66 | 2,22 | -39,34% |
12 | 2022 | 16,96 | 7,63 | -55,01% |
13 | 2016 | 12,11 | 3,66 | -69,78% |
14 | 2024 | 9,20 | 1,77 | -80,76% |
15 | 2011 | 12,28 | 2,01 | -83,63% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2011 | 12,28 | 2,01 | -83,63% |
2 | 2024 | 9,20 | 1,77 | -80,76% |
3 | 2016 | 12,11 | 3,66 | -69,78% |
4 | 2022 | 16,96 | 7,63 | -55,01% |
5 | 2017 | 3,66 | 2,22 | -39,34% |
6 | 2012 | 2,01 | 1,24 | -38,31% |
7 | 2019 | 6,44 | 4,60 | -28,57% |
8 | 2025 | 1,77 | 1,27 | -28,25% |
9 | 2021 | 21,00 | 16,96 | -19,24% |
10 | 2023 | 7,63 | 9,20 | 20,58% |
11 | 2014 | 3,71 | 6,32 | 70,35% |
12 | 2015 | 6,32 | 12,11 | 91,61% |
13 | 2018 | 2,22 | 6,44 | 190,09% |
14 | 2013 | 1,24 | 3,71 | 199,19% |
15 | 2020 | 4,60 | 21,00 | 356,52% |